Chagala Group Limited:企業の戦略・SWOT・財務情報

◆英語タイトル:Chagala Group Limited - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C0869
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カザフスタン
◆産業分野:建設・建築
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Chagala Group Limited – Strategy, SWOT and Corporate Finance Report
Summary

Chagala Group Limited – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Chagala Group Limited (Chagala) owns and operates hotels, apartments and office space in Kazakhstan. The company’s properties comprise 900 apartments and hotel rooms across six cities, Atyrau, Bautino, Almaty, Aktau, Uralsk and Aksai. It also owns 14 food and beverage outlets and 17,000 square meters of office space and 550,000 square meters of development land. The company’s hotel and apartment units offer television, telephone, internet, air conditioning and refrigerator in each room. Other facilities include parking, laundry, gift shop, ATM and currency exchange, and safes at reception. The hotels also offer gymnasium, sauna, Turkish bath, two indoor tennis courts, a beach volley ball court, games room, a children’s playground area, golf simulator, an outdoor swimming pool and a fully stocked lounge bar and terrace. Chagala is headquartered in Almaty, Kazakhstan.

Scope

- Detailed information on Chagala Group Limited required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Chagala Group Limited in the form of a SWOT analysis
- An in-depth view of the business model of Chagala Group Limited including a breakdown and examination of key business segments
- Intelligence on Chagala Group Limited’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Chagala Group Limited, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Chagala Group Limited and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Chagala Group Limited as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Chagala Group Limited’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
Chagala Group Limited: Company Overview 6
Chagala Group Limited: Overview and Key Facts 6
Chagala Group Limited: Overview 6
Chagala Group Limited: Key Facts 6
Chagala Group Limited: Key Employees 7
Chagala Group Limited: Key Employee Biographies 8
Chagala Group Limited: Major Products and Services 9
Chagala Group Limited: Company History 10
Chagala Group Limited: Management Statement 11
Chagala Group Limited: Locations and Subsidiaries 12
Chagala Group Limited: Key Competitors 13
Chagala Group Limited: Company Analysis 14
Chagala Group Limited: Business Description 14
Chagala Group Limited: SWOT Analysis 15
Chagala Group Limited: SWOT Overview 15
Chagala Group Limited: Strengths 15
Chagala Group Limited: Weaknesses 16
Chagala Group Limited: Opportunities 16
Chagala Group Limited: Threats 17
Chagala Group Limited: Recent Developments 18
Chagala Group Limited: News and Events Summary 18
Chagala Group Limited: Corporate Governance 18
Chagala Group Limited: Financial Performance 19
Appendix 20
Contact Us 20
Methodology 20
About MarketLine 21

List of Tables
Table 1: Chagala Group Limited: Key Facts
Table 2: Chagala Group Limited: Key Employees
Table 3: Chagala Group Limited: Locations and Subsidiaries
Table 4: Chagala Group Limited: Key Competitors
Table 5: Chagala Group Limited: News and Events Summary
Table 6: Chagala Group Limited: Corporate Governance
Table 7: Chagala Group Limited: Financial Performance



★海外企業調査レポート[Chagala Group Limited:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Vivus Inc (VVUS):製薬・医療:M&Aディール及び事業提携情報
    Summary Vivus Inc (Vivus) is a biopharmaceutical company which develops and commercializes next-generation therapeutics for addressing unmet needs in obesity, sleep apnea, diabetes and sexual health. The company's marketed products include, Qsymia (phentermine and topiramate extended-release), indic …
  • Ambu AS (AMBU B):企業の財務・戦略的SWOT分析
    Ambu AS (AMBU B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Georgetown University:製薬・医療:M&Aディール及び事業提携情報
    Summary Georgetown University (GU) is an academic and research institute that offers educational services. The university provides undergraduate and graduate degree programs in the fields of law, medical, medical residencies, business administration and public policy degrees, post-doctoral positions …
  • VisionQuest Biomedical LLC:企業の製品パイプライン分析2018
    Summary VisionQuest Biomedical LLC (VisionQuest) is a medical device company that develops medical imaging tools for the diagnostic services. The company’s products include eyestar, DR-RACS, and neurotherm. Its eyestar product is a total eye disease screening program package, DR-RACS is an automated …
  • Codiak BioSciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Codiak BioSciences Inc (Codiak BioSciences) is an exosome therapeutics company that focuses on the development of proprietary pipeline of targeted medicines for diseases with unmet medical needs. The company’s platform capitalizes on exosomes, which are nanometer-sized membrane sacs that del …
  • Pendopharm-製薬・医療分野:企業M&A・提携分析
    Summary PendoPharm is a healthcare company that offers production and commercialization of a wide range of drugs. The company’s products comprise spans prescription drugs, over-the-counter and behind-the-counter products. Its prescription products offers drugs for therapeutic areas of gastroenterolo …
  • China National Petroleum Corporation-石油・ガス分野:企業M&A・提携分析
    Summary China National Petroleum Corporation (CNPC) is an integrated oil and gas company that produces and supplies oil and gas and petrochemical products. The company explores, develops and produces hydrocarbons in onshore and offshore areas of China, Canada, Africa, Central Asia and Russia, Latin …
  • McPherson’s Ltd (MCP):企業の財務・戦略的SWOT分析
    McPherson's Ltd (MCP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Genentech Inc-医療機器分野:企業M&A・提携分析
    Summary Genentech Inc (Genentech), a subsidiary of F. Hoffmann-La Roche Ltd, is a biotechnology company that develops and markets medicines to address serious medical needs. Its clinical development pipeline includes alectinib and Erlotinib for metastatic non-small cell lung cancer; Anti-ST2 for ast …
  • Regeneron Pharmaceuticals Inc (REGN):製薬・医療:M&Aディール及び事業提携情報
    Summary Regeneron Pharmaceuticals Inc (Regeneron) is a biopharmaceutical company, which discovers, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. The company’s six US FDA-approved medicines and product candidates in development help patients wit …
  • McWane Inc:企業の戦略的SWOT分析
    McWane Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Merit Medical Systems Inc (MMSI):企業の財務・戦略的SWOT分析
    Merit Medical Systems Inc (MMSI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Teijin Limited:企業の戦略・SWOT・財務分析
    Teijin Limited - Strategy, SWOT and Corporate Finance Report Summary Teijin Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Natus Medical Incorporated (BABY)-医療機器分野:企業M&A・提携分析
    Summary Natus Medical Incorporated (Natus) is a provider of newborn and neurology healthcare products. Its offers wide range of products for the screening, diagnosis, detection, treatment, monitoring and tracking of ailments in newborn. Natus also offers products for diagnostic hearing assessment in …
  • Innovation Pharmaceuticals Inc (IPIX)-医療機器分野:企業M&A・提携分析
    Summary Innovation Pharmaceuticals Inc (Innovation Pharmaceuticals), formerly Cellceutix Corp is a biopharmaceutical company that discovers and advances medical therapies with dermatology, oncology, anti-inflammatory and antibiotic applications. The company pipeline products include kevetrin for the …
  • J&P – Avax Sa
    J&P - Avax Sa - Strategy, SWOT and Corporate Finance Report Summary J&P - Avax Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Exosome Diagnostics Inc:企業の製品パイプライン分析
    Summary Exosome Diagnostics Inc (Exosome Diagnostics) is a provider of diagnostic solutions. The company develops, designs, manufactures and markets biofluid-based molecular diagnostic tests and products for use in personalized medicine. Exosome Diagnostics’ services comprise miRNA profiling, mRNA p …
  • Rose Petroleum plc (ROSE):石油・ガス:M&Aディール及び事業提携情報
    Summary Rose Petroleum plc (Rose Petroleum), formerly Vane Minerals plc is an oil and gas company. The company explores and produce oil and gas, silver, gold, copper, and uranium deposits across the US and Mexico. Its oil and gas project is located in Paradox Basin in Utah, the US, which covers over …
  • CH. Karnchang Public Company Limited (CK):企業の財務・戦略的SWOT分析
    CH. Karnchang Public Company Limited (CK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Empresa Electrica Corani SA (COR1U):電力:M&Aディール及び事業提携情報
    Summary Empresa Electrica Corani SA (Empresa Electrica), a subsidiary of Empresa Nacional de Electricidad Bolivia, is a renewable energy company that develops and operates hydroelectric power plants and wind farms. The company offers operation and maintenance, project development, and technical serv …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆